434 related articles for article (PubMed ID: 19564244)
1. Prostate cancer: current evidence weighs against population screening.
Boyle P; Brawley OW
CA Cancer J Clin; 2009; 59(4):220-4. PubMed ID: 19564244
[No Abstract] [Full Text] [Related]
2. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
Carroll PR; Whitson JM; Cooperberg MR
J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
[No Abstract] [Full Text] [Related]
3. [Screening for prostatic cancer].
Pushkar' DIu; Govorov AV; Bormotin AV
Urologiia; 2003; (1):10-5. PubMed ID: 12621959
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer: to screen or not to screen?
Shteynshlyuger A; Andriole GL
Urol Clin North Am; 2010 Feb; 37(1):1-9, Table of Contents. PubMed ID: 20152514
[TBL] [Abstract][Full Text] [Related]
5. Screening for prostate cancer.
Brawley OW; Ankerst DP; Thompson IM
CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
Hayes JH; Barry MJ; Kantoff PW; Stahl JE
BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
[No Abstract] [Full Text] [Related]
7. Risk factors, prevention and early detection of prostate cancer.
Loeb S; Schaeffer EM
Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening. Why the controversy?
Walther PJ
Surg Oncol Clin N Am; 1995 Apr; 4(2):315-34. PubMed ID: 7540938
[TBL] [Abstract][Full Text] [Related]
9. A message from preventive medicine and your physician. Prostate cancer.
Prev Med; 2000 Aug; 31(2 Pt 1):101-2. PubMed ID: 10938208
[No Abstract] [Full Text] [Related]
10. Prostate cancer screening.
Catalona WJ
BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
[No Abstract] [Full Text] [Related]
11. Clinical inquiries. Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?
Fisher M; Beck E
J Fam Pract; 2002 Feb; 51(2):113. PubMed ID: 11978206
[No Abstract] [Full Text] [Related]
12. Prostate cancer screening: the need for problem-solving that puts men's interests first.
Holmberg L
Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132
[No Abstract] [Full Text] [Related]
13. In this issue: mini-theme on geriatric care and cancer screening.
Bowman MA; Neale AV
J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726
[No Abstract] [Full Text] [Related]
14. Is screening for prostate cancer the current gold standard?--"yes".
Lange PH
Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
[No Abstract] [Full Text] [Related]
15. Screening for prostate cancer: the role of prostate-specific antigen.
Ferrer RL
Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
[No Abstract] [Full Text] [Related]
16. Rural residence and prostate cancer screening with prostate-specific antigen.
Stamatiou K; Skolarikos A
Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific antigen screening and active surveillance in the elderly.
Konety BR
J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925
[No Abstract] [Full Text] [Related]
18. Prostate cancer screening; is this a teachable moment?
Brawley OW
J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
[No Abstract] [Full Text] [Related]
19. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
20. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
Roobol MJ; Schröder FH
J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
